Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
25.31
+0.74 (3.01%)
At close: Nov 4, 2026, 4:00 PM EST
25.20
-0.11 (-0.42%)
After-hours: Nov 4, 2026, 7:30 PM EST
Elanco Animal Health Revenue
Elanco Animal Health had revenue of $1.37B in the quarter ending June 30, 2026, with 10.23% growth. This brings the company's total for the last twelve months to $5.02B, up 11.95% year-over-year. In the year 2025, Elanco Animal Health had annual revenue of $4.72B with 6.22% growth. That makes Elanco Animal Health the 2,623rd largest company in the world by revenue and 762nd in the United States.
Revenue (ttm)
$5.02B
Revenue Growth
+11.95%
P/S Ratio
2.52
Revenue / Employee
$507,071
Employees
9,900
Market Cap
12.65B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full Elanco Animal Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.72B | 276.00M | 6.22% |
| Dec 31, 2024 | 4.44B | 22.00M | 0.50% |
| Dec 31, 2023 | 4.42B | 6.00M | 0.14% |
| Dec 31, 2022 | 4.41B | -353.00M | -7.41% |
| Dec 31, 2021 | 4.76B | 1.49B | 45.64% |
| Dec 31, 2020 | 3.27B | 200.00M | 6.51% |
| Dec 31, 2019 | 3.07B | 4.20M | 0.14% |
| Dec 31, 2018 | 3.07B | 177.80M | 6.15% |
| Dec 31, 2017 | 2.89B | -24.50M | -0.84% |
| Dec 31, 2016 | 2.91B | 4.40M | 0.15% |
| Dec 31, 2015 | 2.91B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Haleon | 14.80B |
| Viatris | 14.74B |
| Zoetis | 9.53B |
| Neurocrine Biosciences | 3.70B |
| Dr. Reddy's Laboratories | 3.44B |
| Amneal Pharmaceuticals | 3.20B |
| United Therapeutics | 3.15B |
| Hims & Hers Health | 2.58B |
ELAN News
- 1 day ago - Elanco to Participate in UBS Global Healthcare Conference - PRNewsWire
- 6 days ago - Elanco price target lowered to $25 from $26 at Morgan Stanley - TheFly
- 13 days ago - Elanco CPO Dave Kinard to retire, Jamie Preston to succeed - TheFly
- 13 days ago - Elanco Animal Health Appoints Jamie Preston as Chief People Officer - PRNewsWire
- 15 days ago - Elanco downgraded to Hold from Buy at Jefferies - TheFly
- 19 days ago - Elanco initiated with a Buy at Goldman Sachs - TheFly
- 27 days ago - What Growing Up on a Farm Taught Elanco's CEO - WSJ
- 6 weeks ago - Elanco Animal Health Transcript: Bank of America Global Healthcare Conference - Transcripts